SL Chawla

Activity of R1507, a monoclonal antibody to the insulin-like growth factor-1 receptor (IGF1R), in patients (pts) with recurrent or refractory Ewing's sarcoma family of tumors (ESFT): Results of a phase II SARC study.

Alberto S. Pappo, Shreenal Patel, J. Crowley et al. · Journal of Clinical Oncology · 2010 · 43 citations

Medicine, Oncology, Pharmacotherapy +15

Phase I multicenter trial of perifosine in combination with sorafenib for patients with advanced cancers including renal cell carcinoma

Marshall T. Schreeder, Robert A. Figlin, Joseph J. Stephenson et al. · Journal of Clinical Oncology · 2008 · 15 citations

Medicine, Oncology, Pharmacology +9